Table 1.
Pathological events | Molecules/Genes | Impact on microglial function | References | |
---|---|---|---|---|
Microglia and Aβ | SR-A | promote microglia adhesion to Aβ and increase microglia uptake of Aβ | Frenkel et al. (2013) | |
CD36 | play a dichotomous role in Aβ phagocytosis | Kim et al. (2017) | ||
RAGE | play a dichotomous role in Aβ phagocytosis | Deane et al. (2012) | ||
APOE | APOE ε4 genotype is related to a dampened microglial response to amyloid plaques | Nguyen et al. (2020) | ||
CR1 | promote the phagocytosis of Aβ by microglia | Crehan et al. (2013) | ||
TREM2 | play a dichotomous role in Aβ phagocytosis | Ulland et al. (2017) | ||
CD33 | reduce the phagocytosis of Aβ by microglia | Yin et al. (2017) | ||
ABCA7 | promote the phagocytosis of Aβ by microglia | Aikawa et al. (2019) | ||
Microglia and Neuroinflammation | NLRP3 | aggravate microglia-mediated inflammatory response | Heneka et al. (2013) | |
SOCS | play a protective role by balancing the inflammatory response | Ruganzu et al. (2021) | ||
CX3CR1 | CX3CR1 deficiency aggravates tau phosphorylation | Cho et al. (2011) | ||
Microglia and Tau Pathology | CSF1R | inhibition of CSF1R leads to an attenuation of tau-induced neurodegeneration | Mancuso et al. (2019a); Mancuso et al. (2019b) | |
APOE | APOE ε4 markedly exacerbates tau-mediated neurodegeneration | Shi et al. (2017) | ||
TREM2 | loss of TREM2 function promotes seeding and spreading of neuronal plaque tau aggregates. | Leyns et al. (2019) | ||
Microglia and Mitophagy | HMGB1/RAGE signaling pathways | play an important role in blocking late-stage mitophagy in microglia | Zhang et al. (2020) |
SR, scavenger receptors; RAGE, the receptor for advanced glycation end products; APOE, Apolipoprotein E; CR1, complement receptor 1; TREM2, triggering receptor expressed on myeloid cells 2; ABCA7, ATP-binding cassette transporter A7; NLRP3, the NOD-like receptor family pyrin domain-containing 3; SOCS, suppressors of cytokine signaling; CX3CR1, CX3C chemokine receptor 1; CSF1R, colony-stimulating factor 1 receptor; HMGB1, the high-mobility group box 1.